MSCL
$0.63
-3.077%
Satellos Bioscience Inc.Insider Activity
Last updated: Apr 9, 2025, 3:27 AM ET
Profile
Company Description
Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.
Insider Activity
Financial Data provided by QuoteMedia captures transactions reported on SEDI. To view this company’s financial statements, please visit the Financials & Filings.
Time Range
3 Months
Buys
3
months2 Buys
# of Shares
Sells
3
months0 Sells
# of Shares